MITF靶向药基因PLX4720  司美替尼

1,050

基因名称:MITF  (melanogenesis associated transcription factor)

别名: CMM8,MI,WS2,WS2A,bHLHe32
基因ID:4286
Chromosome(GRCh37) :3 Start: 69788586 End: 70017488 Strand: 1
信号通路: 细胞增殖 
肿瘤干细胞 
遗传相关
靶向药: PLX4720 
司美替尼
化疗药:

简介:该基因编码一个转录因子,包含碱性螺旋环螺旋和亮氨酸拉链结构特征。调节黑素细胞视网膜色素上皮的分化和发育,并负责黑素生成酶基因的色素细胞特异性转录。该基因的杂合子突变引起听觉色素综合征,如Waardenburg综合征2型和Tietz综合征。另外,还发现了编码不同亚型的剪接转录变体。This gene encodes a transcription factor that contains both basic helix-loop-helix and leucine zipper structural features. It regulates the differentiation and development of melanocytes retinal pigment epithelium and is also responsible for pigment cell-specific transcription of the melanogenesis enzyme genes. Heterozygous mutations in the this gene cause auditory-pigmentary syndromes, such as Waardenburg syndrome type 2 and Tietz syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified.
MITF突变与药物:
OVEREXPRESSION
药物:
PLX4720 
Selumetinib (AZD6244) 疾病:
黑色素瘤

常见问题
  • 如何在体龙基因完成所需的检测项目 流程简述 :在线咨询 - 采样送检 - 付款检测 - 检测分析 - 报告结果
查看详情

相关内容

官方客服团队

为您解决烦忧 - 24小时在线 专业服务